AbbVie Announces New Data at ASCO 2026 Demonstrating Breadth and Momentum Across its Next-Generation Oncology Pipeline
Go back to AbbVie Announces New Data at ASCO 2026 Demonstrating Breadth and Momentum Across its Next-Generation Oncology Pipeline| AbbVie (NYSE: ABBV) | Delayed: 227.60 +2.83 (1.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $224.77 | 52 Week High | $68.12 | |||
| Open | $227.31 | 52 Week Low | $50.71 | |||
| Day High | $228.40 | P/E | 49.37 | |||
| Day Low | $226.39 | EPS | $4.61 | |||
| Volume | 314,544 | |||||

